AstraZeneca PLC (AZNCF)
| Previous Close | 122.40 |
| Open | 123.51 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 122.85 - 124.00 |
| 52 Week Range | 93.13 - 125.17 |
| Volume | 4,814 |
| Avg. Volume | 2,887 |
| Market Cap | 163.942B |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | 40.84 |
| EPS (TTM) | 3.03 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.79 (2.39%) |
| Ex-Dividend Date | Aug. 12, 2021 |
| 1y Target Est | N/A |
- Editor's PickYahoo Finance
'We're definitely not doing enough' to help global vaccinations: Former US Commerce Sec.
Former U.S. Commerce Sec. Gary Locke weighs in on the global vaccine equity debate and how the U.S. can better respond to the ongoing pandemic.
- Editor's PickYahoo Finance Video
Pfizer says vaccine is 90.7% effective in kids aged 5 to 11: BBG
Dr. Calvin Sun, The Monsoon Diaries Founder & CEO, Clinical Assistant Professor and Attending Physician in Emergency Medicine in NYC, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
ReutersCOVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines may confer greater protection
Two studies in major medical journals add to evidence that COVID-19 vaccines are safe before and during pregnancy. One study, published in The New England Journal of Medicine on Wednesday https://www.nejm.org/doi/full/10.1056/NEJMc2114466, tracked nearly 18,500 pregnant women in Norway, including about 4,500 who had miscarriages. Researchers found no link between COVID-19 vaccines and risk of first-trimester miscarriage, regardless of whether the vaccines were from Moderna, Pfizer and BioNTech, or AstraZeneca.
